Our first edition of 2022 focuses on Healthcare and Life Sciences. It is a sector that will once again have the spotlight on it this year as we continue to tackle COVID-19 and its subsequent variants. While the pandemic continues to challenge the sector, governments across the region forge ahead with their plans to expand and upgrade healthcare systems and develop robust world-class healthcare infrastructure.
For the region, healthcare is a vital pillar in diversifying its economies, both locally and as medical tourism hubs. To underpin this, healthcare authorities across the region continue to implement frameworks and regulations that provide structure and accountability.
In this edition, you have unique access to great insights and expert commentary on a number of pertinent healthcare regulatory developments. You will find a topical mix of articles; for example, our lawyers discuss vaccines and returning to work during the pandemic. They take you through several other areas, including stem cell research in Bahrain, clinical research laws in Egypt, and Saudi medical device and pharmaceutical laws.Take a read of the edition
Al Tamimi’s Equity Capital Markets team has advised on a USD 4.5 million share repurchase programme for a UK plc listed on Nasdaq Dubai, one of the very few share repurchase programmes that has been carried out for a listed company since the inception of the exchange.
Al Tamimi provided legal and regulatory advice to BLME Holdings plc in relation to a share repurchase programme. The advisory role involved discussions with the DFSA and Nasdaq Dubai on the unique structure of the programme, which was required in order to enable BLME Holdings plc to complete the programme whilst complying with the applicable legal and regulatory requirements of each of the DFSA, Nasdaq Dubai and the UK Companies Act 2006 and to facilitate the programme to be carried out as an off-market repurchase rather than a tender offer.
The firm’s Equity Capital Markets team is led by partner Andrew Tarbuck, who added “The Al Tamimi ECM team is delighted to be involved once again on complex cross-border transactions involving public companies listed in the UAE. The share buy-back for our Nasdaq Dubai listed client, BLME, is a good liquidity event for their existing shareholders”.